Ultimately, a deeper understanding of TNF-α signaling and its interactions with other oncogenic pathways, such as NF-κB, Wnt/β-catenin, and STAT3, will pave the way for more effective and personalized treatments for colon cancer. The gene discussed is STAT3; the disease is colonic neoplasm.